ESS 10-Q report for 2026-03-31

Essex Property Trust, Inc. (ESS) filed a combined Form 10‑Q (Essex Property Trust, Inc. and Essex Portfolio, L.P.) for the quarter ended March 31, 2026. The filing includes unaudited condensed consolidated financial statements and standard Part II disclosures. Key reported items: total assets $13,095,487k; total liabilities $7,468,343k; total equity $5,601,356k; three-month rental and other property revenue $482,443k; net income $112,208k; basic net income per share $1.65; cash and cash equivalents (unrestricted + restricted) $47,410k at quarter-end; net cash provided by operating activities $287,169k; net cash used in investing activities $105,153k; net cash used in financing activities $220,192k.

The provided content is the issuer's Form 10‑Q for the quarter ended March 31, 2026, including unaudited condensed consolidated balance sheets, statements of income and comprehensive income, statements of cash flows, and statements of equity/capital for Essex Property Trust, Inc. and Essex Portfolio, L.P. The filing confirms continued reporting compliance, details quarter-over-quarter financial results (rental revenue, operating expenses, depreciation, interest expense, equity income from co-investments), and summarizes capital activity (debt, distributions, share retirements, dividends). As an SEC periodic filing, it is authoritative for reported historical financial data but does not by itself provide new forward guidance or event-driven catalysts. Use these financials to validate reported performance, liquidity and capital structure; further analysis should incorporate MD&A commentary and subsequent disclosures for actionable investment decisions.

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

This excerpt is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.